FENNEC PHARMACEUTICALS ($FENC) posted quarterly earnings results for Q1 2026 on Thursday, May 14th. The company reported earnings of $0.01 per share, beating estimates of -$0.01 by $0.02. The company also reported revenue of $15,110,000, beating estimates of $14,233,284 by $876,716.
You can see Quiver Quantitative's $FENC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
FENNEC PHARMACEUTICALS Insider Trading Activity
FENNEC PHARMACEUTICALS insiders have traded $FENC stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $FENC stock by insiders over the last 6 months:
- CAPITAL ADVISORS LP SOUTHPOINT has made 0 purchases and 4 sales selling 1,265,359 shares for an estimated $9,705,673.
- ROSTY RAYKOV has made 0 purchases and 3 sales selling 31,130 shares for an estimated $225,461.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
FENNEC PHARMACEUTICALS Hedge Fund Activity
We have seen 49 institutional investors add shares of FENNEC PHARMACEUTICALS stock to their portfolio, and 37 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOUTHPOINT CAPITAL ADVISORS LP removed 1,332,473 shares (-32.7%) from their portfolio in Q4 2025, for an estimated $10,260,042
- AWM INVESTMENT COMPANY, INC. added 711,869 shares (+inf%) to their portfolio in Q4 2025, for an estimated $5,481,391
- ROSALIND ADVISORS, INC. added 536,668 shares (+25.8%) to their portfolio in Q4 2025, for an estimated $4,132,343
- AIGH CAPITAL MANAGEMENT LLC added 400,000 shares (+25.3%) to their portfolio in Q1 2026, for an estimated $2,460,000
- SOLAS CAPITAL MANAGEMENT, LLC added 372,824 shares (+17.0%) to their portfolio in Q4 2025, for an estimated $2,870,744
- TANG CAPITAL MANAGEMENT LLC removed 334,593 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2,576,366
- APIS CAPITAL ADVISORS, LLC added 204,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,570,800
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
FENNEC PHARMACEUTICALS Price Targets
Multiple analysts have issued price targets for $FENC recently. We have seen 2 analysts offer price targets for $FENC in the last 6 months, with a median target of $15.5.
Here are some recent targets:
- David Nierengarten from Wedbush set a target price of $13.0 on 04/16/2026
- David Amsellem from Piper Sandler set a target price of $18.0 on 01/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
